Sumanta K. Pal, Vice Chair of Academic Affairs and Professor at City of Hope, shared on X by Tom Powles, Professor of Genitourinary Oncology at Barts Cancer Institute and Director of Barts Cancer Centre, adding:
“Terrific work from Aparna Kamat in Annals of Oncology. As I see dozens of studies launching to prospectively interrogate the impact of GLP1 RAs in cancer (including one led by our very own Yun Rose Li, June Rhee, City of Hope), this paper serves as an excellent foundation. Thanks for bringing this to my attention, Tom Powles.”
Quoting Tom Powles:
“In this article in Annals of Oncology, GLP1 receptor agonists reduce cancer incidence. The focus is on those cancers linked to obesity.
A retrospective study with a large sample size in people looking to lose weight. A detailed case/control type method. 41% decrease in cancer with GLP1 injections. It’s not clear if the effects of weight loss or the agonists are having an effect. Validation needed. Great work!”
Title: GLP-1 receptor agonist use and cancer risk in obese nondiabetic adults
Authors: A.H.-C. Hsu, P.T. Ramirez, Y.-H. Chang, Y.-C. Chiang, M.C. Santía, T. Meschini, P. Mateo-Kubach, A. Suri, and A.A. Kamat.
Read The Full Article.
